NUTX at a glance
Nutex Health Inc. (NUTX, SEC CIK 1479681) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on September 11, 2026 and Form 4 insider filings as recently as September 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Nutex Health Inc. (NUTX) reported revenue of $875.3 million (up 82.4% from FY2024) and net income of $70.8 million. Diluted EPS was $10.48.
- As of June 30, 2026, 26 institutional investment managers tracked by SignalX reported holding Nutex Health Inc. (NUTX) shares worth $205.6 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Saunders Scott J on September 18, 2026 of 203 shares at $214.25 per share.
- In the last 90 days, NUTX insiders reported 0 open-market purchases ($0) and 1 open-market sale ($43K) on Form 4, a net sale of $43K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $875.3M
- +82.4% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$43K
- 13F holders
- 26 funds
- $205.6M · +1 vs prior quarter
- Latest 8-K
- Sep 11, 2026
- Item 8.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Arbitration-related costs $(12.5)M vs $48.0M YoY, a $60.5M reduction
- Arbitration fee changes reduced contract services expense by $52.3M
- IDR headwinds: processing backlogs, prolonged timelines, eligibility uncertainty, regulatory changes
- Future court decisions and regulatory changes may adversely affect revenue collection
Risk Factors
- No material change stated overall; new IDR risk tied to No Surprises Act portal modifications
- IDR revenue estimates subject to arbitration outcomes and payer behavior, causing quarterly revenue volatility
- Earn-out dispute over approximately 256,005 shares, including 216,039 ABQ Hospital shares
- Former doctor owners challenge 2024 reverse-split adjustments, creating uncertain dilution or cash settlements
- IDR estimation adjustments may materially affect recognized revenue and stock price performance
AI summary of the NUTX 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- Cybersecurity event update issued September 10, 2026
- Exhibit 99.1 contains the substantive incident details and potential shareholder impact
Item 8.01: Other Events
- Cyberattack allegedly exfiltrated patient, employee, provider, business, and financial information
- No material impact identified on operations or financial reporting systems to date
Item 8.01: Other Events
- Unauthorized third party accessed and exfiltrated potentially private or confidential data from Nutex’s network
- Potentially affected information includes patient, employee, provider, financial, business, and intellectual-property data
AI summaries of NUTX 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for NUTX
Don't miss the next NUTX filing
- Alerts as it files. A push when NUTX files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NUTX, by share count.
- Ask anything. An AI agent that reads every NUTX filing and answers with sources.
NUTX alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Saunders Scott J | Sell | Sep 18, 2026 | 203 | $214.25 |
| Saunders Scott J | M | Jul 31, 2026 | 603 | - |
| Jaumot Frank E | M | Jul 31, 2026 | 603 | - |
| Grenas Cheryl Yvonne | M | Jul 31, 2026 | 603 | - |
| Reed Michael Lee | M | Jul 31, 2026 | 603 | - |
| Spears Kelvin | J | Jun 4, 2026 | 2,519 | - |
| Vo Thomas T. | J | May 28, 2026 | 75,747 | - |
| Saunders Scott J | A | Apr 23, 2026 | 823 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $479.9M | $875.3M |
| Gross Profit | - | $196.3M | $444.3M |
| Operating Income | - | $130.6M | $275.6M |
| Net Income | - | $52.2M | $70.8M |
| Gross Margin | - | 40.9% | 50.8% |
| Op. Margin | - | 27.2% | 31.5% |
| Net Margin | - | 10.9% | 8.1% |
| Balance Sheet | |||
| Total Assets | $398.2M | $655.3M | $918.5M |
| Equity | - | $146.3M | $329.4M |
| ROE | - | 35.7% | 21.5% |
| Per Share | |||
| EPS | - | $9.71 | $10.48 |
| Cash Flow | |||
| Operating CF | - | $23.2M | $248.1M |
| CapEx | $9.5M | $2.3M | $2.5M |
Source: XBRL data in Nutex Health Inc. (NUTX)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate NUTX share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 26 | $205.6M |
| Q1 2026 | 25 | $104.9M |
| Q4 2025 | 24 | $156.0M |
| Q3 2025 | 21 | $97.7M |
| Q2 2025 | 20 | $88.1M |
| Q1 2025 | 10 | $13.1M |
| Q4 2024 | 6 | $5.8M |
| Q3 2024 | 3 | $1.1M |
- BlackRock+28.0K (+7%)
- Goldman Sachs Group+17.4K (+52%)
- State Street Corp+7.7K (+6%)
- Northern Trust+2.8K (+7%)
- Wells Fargo & Co+2.7K (+128%)
- Millennium Management−37.5K (-42%)
- Morgan Stanley−23.1K (-54%)
- Vanguard Portfolio Management LLC−5.1K (-13%)
- Raymond James Financial−3.3K (-57%)
- Vanguard Capital Management LLC−3.2K (-1%)
- D.E. Shaw & Co+97.5K
- Citadel Advisors LLC+18.3K
- Two Sigma Investments−10.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 135 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
NUTX filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 18, 2026 | - | - | - |
| 8-K | Sep 11, 2026 | - | Analysis | - |
| 8-K | Aug 31, 2026 | - | Analysis | - |
| 8-K | Aug 24, 2026 | - | Analysis | - |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 4 | Aug 3, 2026 | - | - | - |
| 4 | Aug 3, 2026 | - | - | - |
| 4 | Aug 3, 2026 | - | - | - |
| 4 | Aug 3, 2026 | - | - | - |
| 8-K | Jul 21, 2026 | - | Analysis | - |
| 4 | Jun 4, 2026 | - | - | |
| 4 | May 29, 2026 | - | - | |
| 10-Q | Apr 30, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Apr 30, 2026 | - | Analysis | - |
| SC 13G | Apr 27, 2026 | - | - | |
| 4 | Apr 24, 2026 | - | - | - |
| 4 | Apr 24, 2026 | - | - | - |
| 4 | Apr 24, 2026 | - | - | - |
| 4 | Apr 24, 2026 | - | - | - |
| 8-K | Apr 23, 2026 | - | Analysis | - |
| 4 | Apr 10, 2026 | - | - | - |
| 4 | Mar 24, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
Related Information Technology companies
- ACN · AccentureServices-Business Services, NEC
- ACVA · ACV Auctions Inc.Services-Business Services, NEC
- ADV · Advantage Solutions Inc.Services-Business Services, NEC
- AKAM · Akamai TechnologiesServices-Business Services, NEC
- BABA · Alibaba Group Holding LtdServices-Business Services, NEC
- ALIT · Alight, Inc. / DelawareServices-Business Services, NEC
- CASS · CASS INFORMATION SYSTEMS INCServices-Business Services, NEC
- CBZ · CBIZ, Inc.Services-Business Services, NEC
NUTX SEC filings: frequently asked questions
Are NUTX insiders buying or selling?
In the last 90 days, Nutex Health Inc. (NUTX) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $43,493 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold NUTX stock?
As of June 30, 2026, the largest Nutex Health Inc. (NUTX) holders among the 13F filers tracked by SignalX were BlackRock ($69.6 million), Vanguard Capital Management LLC ($36.9 million), State Street Corp ($22.4 million), D.E. Shaw & Co ($16.7 million), Millennium Management ($8.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was NUTX's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Nutex Health Inc. (NUTX) reported revenue of $875.3 million (up 82.4% from FY2024) and net income of $70.8 million. Diluted EPS was $10.48. The figures come from the XBRL data in the 10-K.
What did NUTX report in its latest 8-K?
Nutex Health Inc. (NUTX) filed an 8-K on September 11, 2026 reporting Item 8.01 (Other Events). Cybersecurity event update issued September 10, 2026.
What are the latest NUTX SEC filings?
Nutex Health Inc. (NUTX) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on September 11, 2026 and a Form 4 insider filing on September 18, 2026.
What is NUTX's SEC CIK number?
Nutex Health Inc. (NUTX)'s SEC Central Index Key (CIK) is 1479681. EDGAR lists every NUTX filing under that number.
Ask anything about NUTX
The research agent reads NUTX's filings, financials, insider trades and 13F holders, then answers with sources.